01 2Gowling WLG (Canada) LLP
02 2McCarthy Tetrault LLP
01 22631938
02 22866128
01 4IXEKIZUMAB
01 4SOLUTION
01 22026-12-05
02 22033-03-01
Patent Expiration Date : 2026-12-05
Date Granted : 2014-05-20
Brand Name : TALTZ
Patent Number : 2631938
Filing Date : 2006-12-05
Strength per Unit : 80 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2026-12-05
Date Granted : 2014-05-20
Patent Expiration Date : 2026-12-05
Date Granted : 2014-05-20
Brand Name : TALTZ
Patent Number : 2631938
Filing Date : 2006-12-05
Strength per Unit : 80 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2026-12-05
Date Granted : 2014-05-20
Patent Expiration Date : 2033-03-01
Date Granted : 2017-02-28
Brand Name : TALTZ
Patent Number : 2866128
Filing Date : 2013-03-01
Strength per Unit : 80 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2033-03-01
Date Granted : 2017-02-28
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2033-03-01
Date Granted : 2017-02-08
Brand Name : TALTZ
Patent Number : 2866128
Filing Date : 2013-03-01
Strength per Unit : 80 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2033-03-01
Date Granted : 2017-02-08
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
